Robert Blum Submits Form 144 for Sale of 22,500 Cytokinetics Shares Acquired via Stock Options
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Robert Blum, a director and officer at Cytokinetics, Incorporated, has filed a Form 144 to sell 22,500 shares of common stock. These shares, valued at